79296-92-7

Upstream product

• 3099-31-8 nicotinyl chloride 
• 603-35-0 triphenylphosphine 
• 6959-48-4 3-chloromethylpyridinium chloride 

Downstream Products

• 2633-06-9 (E)-3-(2-phenylvinyl)pyridine 
• 20934-82-1 (E,Z)-1-(4-hydroxyphenyl)-2-(3-pyridyl)ethylene 
• 85666-07-5 1-(4-hydroxyphenyl)-2-(3-pyridyl)ethane 
• 85666-11-1 1-(3-Hydroxyphenyl)-2-(3-pyridinyl)ethane 
• 85666-12-2 2-Hydroxy-4-[2-(3'-pyridinyl)ethyl]benzaldehyde 
• 96254-52-3 2-Hydroxy-5-(2-pyridin-3-yl-ethyl)-benzaldehyde 
• 388594-38-5 3-[2-(4-chloro-3-nitrophenyl)vinyl]pyridine 
• 6892-33-7 3-[2-(4-methylphenyl)ethenyl]pyridine 
• 134163-38-5 methyl 8-(p-chlorophenylsulfonamido)-4-[3-(pyridin-3-yl)-2-propenyl]-octanoate 
• 51432-67-8 3-(triphenyl-λ⁵-phosphanylidenemethyl)-pyridine 

Relevant academic research and scientific papers

Br?nsted acid-catalysed conjugate addition of photochemically generated α-amino radicals to alkenylpyridines

The conjugate addition of α-amino radicals to alkenylpyridines has been accomplished by the synergistic merger of Br?nsted acid and visible light photoredox catalysis. Key to reaction development was the protonation of the alkenylpyridines that transientl

INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS

Compounds of formula (Ia): wherein R1, R2, R3, R4a, R4b, R5 and R6 are defined herein, as well as other indene derivatives are disclosed herein. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.

Phthalazine derivatives for treating inflammatory diseases

The invention relates to the treatment of an inflammatory disease, especially an inflammatory rheumatoid or rheumatic disease, and/or pain with an inhibitor of the activity of VEGF receptor tyrosine kinase of the formula I, wherein r is 0 to 2, n is 0 to

Synthesis and antiulcer activity of (E)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo [1,5-a]pyrimidine-7-ones.

A series of (E)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo-[1,5-a]pyrimidine-7-ones were synthesized and evaluated for the inhibition of stress-induced gastric ulcers in the rat after oral administration. Several molecules were found to be very active. The particularly interesting compound (E)-1-(3-chlorophenyl)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo[1,5-a]- pyrimidine-7-one was chosen for wider pharmacological investigation.

SYNTHESIS OF CAROTENOID ANALOGUES HAVING PYRIDINE, FURAN, AND TIOPHENE RINGS AS TERMINAL GROUPS

Heteroaromatic carotenoid analogues having 2-pyridyl, 3-pyridyl, 2-furyl, 3-furyl, 2-thienyl, and 3-thienyl groups at both the ends of tetramethyloctadecanonaene chain, were synthesized and their spectral properties were examined.